Tolerability and Pharmacokinetics(PK)/Pharmacodynamics(PD) Study of GW003 in Healthy Subjects

NCT02643901 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

26

Enrollment

INDUSTRY

Sponsor class

Conditions

Chemotherapy-induced Neutropenia

Interventions

BIOLOGICAL: GW003

Sponsor

Jiangsu T-Mab Biopharma Co.,Ltd